Virtual Medicinal Product (VMP) - Empagliflozin 25mg / Linagliptin 5mg tablets
Name Details
| Name | Start Date | End Date | |
|---|---|---|---|
| Name | Current Name Empagliflozin 25mg / Linagliptin 5mg tablets | Start Date 01-06-2019 | End Date |
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1
- UDFS UOM
- tablet
- Unit Dose UOM
- tablet
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Oral
- Form
- Oral tablet
- Ontology Form/Route
- tablet.oral
- Name Basis
- Other
Codes
- ATC Code
- A10BD19
- BNF Codes
-
- BNF code 06010203
| Code | Start Date | End Date |
|---|---|---|
| 37280511000001103 | 01-06-2019 |
VMP Ingredients
| Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
|---|---|---|---|---|
| Empagliflozin | Based on Ingredient Substance | 25 mg | ||
| Linagliptin | Based on Ingredient Substance | 5 mg |
Name
Linagliptin
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
5
Strength and UOM (Dmr)
Name
Empagliflozin
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
25
Strength and UOM (Dmr)
Parent Products
-
VTMEmpagliflozin + Linagliptin
-
VMP(Current) Empagliflozin 25mg / Linagliptin 5mg...
-
AMP
-
-
Virtual Medicinal Product Pack (VMPP) Information
| Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
|---|---|---|
| 28 tablet | 5588 | Part VIIIA Category C |